Stephen E. Kimmel, M.D., MSCE, an international leader in clinical epidemiology and cardiovascular epidemiology, has been named chair of the UF department of epidemiology. He will join the faculty in December.
Kimmel currently is a professor of medicine and epidemiology at the Perelman School of Medicine at the University of Pennsylvania, where he has helped develop and lead a nationally acclaimed program devoted to advancing epidemiology research and education. He serves as director of the division of epidemiology in the department of biostatistics, epidemiology and informatics and director of the clinical epidemiology unit in the Center for Clinical Epidemiology and Biostatistics. He is also the founding director of the Center for Therapeutic Effectiveness Research.
Kimmel’s research, which has been funded continuously for the past 25 years, focuses on improving the use of existing medical therapies, particularly those related to genetic epidemiology, treatment adherence and patient-centered outcomes. He has served as principal investigator on numerous federal grants totaling more than $40 million in funding.
Kimmel has been instrumental in developing the University of Pennsylvania’s education programs in the field of epidemiology, including the master of science degree in clinical epidemiology, the doctorate degree in epidemiology and the certificate in clinical research. He has been recognized a number of times for his teaching and mentoring and has served as a primary mentor for 32 trainees.
A graduate of Princeton University and New York University School of Medicine, Kimmel completed his internal medicine training at Harvard’s Brigham and Women’s Hospital and his cardiology fellowship at the University of Pennsylvania. He has a master of science degree in clinical epidemiology from the Perelman School of Medicine.
At UF, Kimmel will lead a dynamic department that offers master’s, doctoral and certificate programs and is home to two T32 training grants. Faculty members are conducting research on big data, chronic disease, community engagement, health disparities, infectious diseases, precision medicine and substance abuse, to name a few.
